- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: OX40 ligand (OX40)
Total 593 results
-
Merck Sharp & Dohme LLCEuropean Organisation for Research and Treatment of CancerActive, not recruiting
-
Karuna TherapeuticsActive, not recruiting
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)SuspendedStage II Bladder Cancer AJCC v8 | Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall | Infiltrating Renal Pelvis and Ureter Urothelial CarcinomaUnited States
-
University Hospital, MontpellierTerminatedFemale With Osteoporosis and Chronic Kidney DiseaseFrance
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompletedRichter Syndrome | Mediastinal Large B-cell Lymphoma
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompletedHead and Neck Squamous Cell Cancer
-
Merck Sharp & Dohme LLCCompleted
-
University Hospital OstravaCompleted
-
MedImmune LLCCompletedSolid TumorsUnited States, Korea, Republic of, Australia
-
Merck Sharp & Dohme LLCActive, not recruitingCarcinoma, HepatocellularKorea, Republic of, China, Hong Kong, Malaysia, Taiwan
-
PrECOG, LLC.AstraZenecaCompletedMesothelioma | Pleural MesotheliomaUnited States
-
Merck Sharp & Dohme LLCActive, not recruitingUrothelial CarcinomaAustralia, United States, Chile, Denmark, Israel, Korea, Republic of, Spain
-
Pharmtechnology LLCLigand Research, LLCCompletedBioequivalenceRussian Federation
-
Merck Sharp & Dohme LLCActive, not recruitingRenal Cell CarcinomaUnited States, Argentina, Australia, Brazil, Canada, Chile, Colombia, Czechia, Finland, France, Germany, Ireland, Italy, Japan, Korea, Republic of, Netherlands, Poland, Russian Federation, Spain, Taiwan, United Kingdom
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedBiochemically Recurrent Prostate CarcinomaUnited States
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruiting
-
Merck Sharp & Dohme LLCCompleted
-
Jonsson Comprehensive Cancer CenterCompletedProstate Adenocarcinoma | Stage IV Prostate Cancer AJCC v7 | Stage III Prostate Cancer AJCC v7 | Stage IIB Prostate Cancer AJCC v7United States
-
Merck Sharp & Dohme LLCActive, not recruitingCarcinoma, Non-Small-Cell Lung | Solid Tumor | Pharmacokinetics | Triple Negative Breast NeoplasmsUnited States, Chile, Israel, Korea, Republic of, Netherlands, Spain, Taiwan
-
Merck Sharp & Dohme LLCCompleted
-
EMD Serono Research & Development Institute, Inc.Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt...TerminatedTriple Negative Breast NeoplasmsUnited States, France, Belgium, Spain, Russian Federation, Italy
-
Merck Sharp & Dohme LLCTerminatedGastric Neoplasms | Gastroesophageal Junction AdenocarcinomaChina, Korea, Republic of, Malaysia, Taiwan
-
Merck Sharp & Dohme LLCCompletedEsophageal Carcinoma | Esophagogastric Junction CarcinomaChina
-
Merck Sharp & Dohme LLCCompletedMetastatic Castration-resistant Prostate Cancer
-
Ionis Pharmaceuticals, Inc.CompletedAcromegalyUnited States, Serbia, Poland, Russian Federation, Hungary, Lithuania
-
European Organisation for Research and Treatment...CompletedOvarian NeoplasmsSpain, Switzerland, Netherlands, United Kingdom, France
-
Merck Sharp & Dohme LLCCompletedEsophageal Carcinoma | Esophagogastric Junction Carcinoma
-
Hospices Civils de LyonTerminatedSelection of Farnesoid X Receptor (FXR) Ligands on the Reactivation of Latent HIV Proviruses (FXR#2)Human Immunodeficiency Virus I InfectionFrance
-
Al-Azhar UniversityCompletedChronic PeriodontitisEgypt
-
Merck Sharp & Dohme LLCCompleted
-
Incyte CorporationCompletedHead and Neck Cancer | Gastric Cancer | Lung Cancer | Metastatic Cancer | Mesothelioma | Bladder Cancer | Solid Tumors | Renal Cell Carcinoma (RCC) | Colorectal Cancer (CRC) | UC (Urothelial Cancer)Italy, Spain, United States, Netherlands
-
Centre Hospitalier Sud FrancilienCompleted
-
Northwell HealthCompletedSystemic Lupus ErythematosusUnited States
-
Janssen Research & Development, LLCCompleted
-
OX2 TherapeuticsActive, not recruiting
-
Necmettin Erbakan UniversityCompletedDental Implant | Alveolar Bone Loss | PeriimplantitisTurkey
-
Nucorion Pharmaceuticals, Inc.Ligand PharmaceuticalsCompletedChronic Hepatitis BUnited States
-
AstraZenecaCompletedAdvanced Solid MalignanciesUnited States, Germany, Italy, United Kingdom, Canada, France, Korea, Republic of, Netherlands
-
Merck Sharp & Dohme LLCCompletedNon-Small Cell Lung CancerUnited States, Canada, Hungary, Israel, Spain
-
Ionis Pharmaceuticals, Inc.CompletedAcromegalyUnited States, Hungary, Serbia, Romania, Russian Federation, Lithuania, Poland
-
Merck Sharp & Dohme LLCTerminatedNeoplasm MetastasisUnited States, Canada, Israel
-
Merck Sharp & Dohme LLCCompleted
-
Jonsson Comprehensive Cancer CenterTerminatedBiochemically Recurrent Prostate Carcinoma | Metastatic Prostate Carcinoma | Metastatic Malignant Neoplasm in the Bone | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Stage IV Prostate Cancer American Joint Committee on Cancer (AJCC) v8United States
-
Merck Sharp & Dohme LLCActive, not recruitingMelanoma | Carcinoma, Non-Small-Cell LungIndia
-
University of California, San FranciscoRadiological Society of North AmericaCompletedOvarian CarcinomaUnited States
-
Merck Sharp & Dohme LLCCompletedSmall Cell Lung Cancer (SCLC)United States, Australia, Canada, Chile, France, Germany, Hungary, Ireland, Israel, Japan, Korea, Republic of, New Zealand, Poland, Russian Federation, Spain, Switzerland, Taiwan, Turkey, United Kingdom
-
Atara BiotherapeuticsMerck Sharp & Dohme LLCTerminatedNasopharyngeal Carcinoma | Nasopharyngeal Neoplasms | Epstein-Barr Virus Infections | Epstein-Barr Viraemia | Epstein-Barr Virus-associated Nasopharyngeal Carcinoma (EBV+ NPC)United States
-
Merck Sharp & Dohme LLCCompleted